Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-12

AUTHORS

Tsuyoshi Miyahara, Naoko Sueoka-Aragane, Kentaro Iwanaga, Norio Ureshino, Kazutoshi Komiya, Tomomi Nakamura, Chiho Nakashima, Tomonori Abe, Hisashi Matsunaga, Shinya Kimura

ABSTRACT

Pemetrexed is a key anticancer agent for treatment of advanced non-small cell lung cancer (NSCLC). Pemetrexed is generally well tolerated, but individual-patient differences exist in severity of adverse events. Our study aimed to characterize the adverse events of pemetrexed that result in discontinuation of chemotherapy and to identify risk factors associated with those adverse events. We retrospectively studied the incidence of adverse events in 257 patients with NSCLC who received pemetrexed (P) with or without bevacizumab (B) and/or carboplatin (C): P, PB, CP, or CPB. Patients whose chemotherapy was discontinued were divided into two groups according to adverse events and disease progression. Grade 2/3 nausea, fatigue with P and PB, and rash with CP and CPB occurred more frequent in the adverse events group than in the disease progression group. Multivariate analysis indicated that grade 2/3 nausea [odds ratio (OR) 9.94; 95% confidence interval (CI) 1.46-67.37; p = 0.01] and fatigue (OR 10.62; CI 1.60-70.20; p = 0.01) with P or PB, and rash (OR 6.12; CI 1.34-27.88; p = 0.01) with CP or CPB, were independent risk factors for discontinuation of chemotherapy. Administration of dexamethasone at doses less than 4 mg after the day of pemetrexed administration was associated with nausea following P or PB (OR 11.08; 95% CI 1.02-119.95; p = 0.04). Grade 2/3 nausea and fatigue with P or PB, and rash with CP or CPB, were associated with discontinuation of chemotherapy. More... »

PAGES

195

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12032-017-1053-8

DOI

http://dx.doi.org/10.1007/s12032-017-1053-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092595156

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29124473


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fatigue", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nausea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pemetrexed", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Saga-Ken Medical Centre Koseikan", 
          "id": "https://www.grid.ac/institutes/grid.416533.6", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan", 
            "Department of Pharmacy, Saga-Ken Medical Centre Koseikan, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Miyahara", 
        "givenName": "Tsuyoshi", 
        "id": "sg:person.01114031552.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114031552.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sueoka-Aragane", 
        "givenName": "Naoko", 
        "id": "sg:person.01014670366.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014670366.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga-Ken Medical Centre Koseikan", 
          "id": "https://www.grid.ac/institutes/grid.416533.6", 
          "name": [
            "Division of Respiratory Medicine, Saga-Ken Medical Centre Koseikan, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Iwanaga", 
        "givenName": "Kentaro", 
        "id": "sg:person.01372477264.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372477264.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga-Ken Medical Centre Koseikan", 
          "id": "https://www.grid.ac/institutes/grid.416533.6", 
          "name": [
            "Division of Medical Oncology, Saga-Ken Medical Centre Koseikan, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ureshino", 
        "givenName": "Norio", 
        "id": "sg:person.01236516200.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236516200.77"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Komiya", 
        "givenName": "Kazutoshi", 
        "id": "sg:person.01055604713.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055604713.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakamura", 
        "givenName": "Tomomi", 
        "id": "sg:person.01352744600.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352744600.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nakashima", 
        "givenName": "Chiho", 
        "id": "sg:person.010703513405.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010703513405.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Abe", 
        "givenName": "Tomonori", 
        "id": "sg:person.01307617466.20", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307617466.20"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga-Ken Medical Centre Koseikan", 
          "id": "https://www.grid.ac/institutes/grid.416533.6", 
          "name": [
            "Department of Pharmacy, Saga-Ken Medical Centre Koseikan, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsunaga", 
        "givenName": "Hisashi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Saga University", 
          "id": "https://www.grid.ac/institutes/grid.412339.e", 
          "name": [
            "Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kimura", 
        "givenName": "Shinya", 
        "id": "sg:person.016704032752.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016704032752.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.2478/raon-2013-0086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005021102"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199107183250305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005599331"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/bpb.b15-00162", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005897873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.57.2347", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007601946"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67110-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009533002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.0375", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011587624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2354.2007.00797.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011948574"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70063-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012995827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1248/bpb.b15-00435", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014744057"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.4614", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014939429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2004.08.163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016594110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3078-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017315212", 
          "https://doi.org/10.1007/s00280-016-3078-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3078-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017315212", 
          "https://doi.org/10.1007/s00280-016-3078-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.jto.0000268672.57002.69", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017316702"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.critrevonc.2008.01.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036054386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.48.1911", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036238424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-011-1248-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041097987", 
          "https://doi.org/10.1007/s00520-011-1248-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.6406", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044485340"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-015-0852-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044954901", 
          "https://doi.org/10.1007/s10147-015-0852-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(99)06290-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046217291"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1758834016644155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1758834016644155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077386"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2015.65.4327", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204500"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1075203218", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083239815", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0171066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083533995"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "Pemetrexed is a key anticancer agent for treatment of advanced non-small cell lung cancer (NSCLC). Pemetrexed is generally well tolerated, but individual-patient differences exist in severity of adverse events. Our study aimed to characterize the adverse events of pemetrexed that result in discontinuation of chemotherapy and to identify risk factors associated with those adverse events. We retrospectively studied the incidence of adverse events in 257 patients with NSCLC who received pemetrexed (P) with or without bevacizumab (B) and/or carboplatin (C): P, PB, CP, or CPB. Patients whose chemotherapy was discontinued were divided into two groups according to adverse events and disease progression. Grade 2/3 nausea, fatigue with P and PB, and rash with CP and CPB occurred more frequent in the adverse events group than in the disease progression group. Multivariate analysis indicated that grade 2/3 nausea [odds ratio (OR) 9.94; 95% confidence interval (CI) 1.46-67.37; p\u00a0=\u00a00.01] and fatigue (OR 10.62; CI 1.60-70.20; p\u00a0=\u00a00.01) with P or PB, and rash (OR 6.12; CI 1.34-27.88; p\u00a0=\u00a00.01) with CP or CPB, were independent risk factors for discontinuation of chemotherapy. Administration of dexamethasone at doses less than 4\u00a0mg after the day of pemetrexed administration was associated with nausea following P or PB (OR 11.08; 95% CI 1.02-119.95; p\u00a0=\u00a00.04). Grade 2/3 nausea and fatigue with P or PB, and rash with CP or CPB, were associated with discontinuation of chemotherapy.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12032-017-1053-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094524", 
        "issn": [
          "1357-0560", 
          "1559-131X"
        ], 
        "name": "Medical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "34"
      }
    ], 
    "name": "Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer", 
    "pagination": "195", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "fea40887dbeb99fea78c82970895b0b0ef40758882bf1bb4e65fb44d0afc4a8c"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29124473"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9435512"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12032-017-1053-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092595156"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12032-017-1053-8", 
      "https://app.dimensions.ai/details/publication/pub.1092595156"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000609.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12032-017-1053-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-017-1053-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-017-1053-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-017-1053-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-017-1053-8'


 

This table displays all metadata directly associated to this object as RDF triples.

266 TRIPLES      21 PREDICATES      67 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12032-017-1053-8 schema:about N0d03cdc47a1a419da0499b54ad2881de
2 N13d348274d824300af66bc978eefb86d
3 N38d1c128e78c442cb87978823b427cb2
4 N4cb6ba5c46424095a04c20a69f8ee2f0
5 N51b70b1b5e134934b62852ef6c480464
6 N600175f54eeb40408804da710c765f08
7 N7491dac1c2254bbcb7241ad2b89c18c3
8 N90690f330828419bb8b71f443338520e
9 N9096378dd6d7460995607a97b36920af
10 Nbc40e6a547774419929b7a1d0e682eb3
11 Nc9eb825383e846c4892ad47dd4da1929
12 Nee876fad41fc4ad5826644f43b5ed165
13 Nf069d7ec36b14e7abb7a35f67fd72258
14 Nf6a7814805734dfdb8f7534656979d3b
15 anzsrc-for:11
16 anzsrc-for:1112
17 schema:author N20abdf57895d4aeaa57ca50349774574
18 schema:citation sg:pub.10.1007/s00280-016-3078-7
19 sg:pub.10.1007/s00520-011-1248-z
20 sg:pub.10.1007/s10147-015-0852-1
21 https://app.dimensions.ai/details/publication/pub.1075203218
22 https://app.dimensions.ai/details/publication/pub.1083239815
23 https://doi.org/10.1016/j.critrevonc.2008.01.011
24 https://doi.org/10.1016/s0140-6736(05)67110-3
25 https://doi.org/10.1016/s0140-6736(99)06290-x
26 https://doi.org/10.1016/s1470-2045(12)70063-3
27 https://doi.org/10.1056/nejm199107183250305
28 https://doi.org/10.1097/01.jto.0000268672.57002.69
29 https://doi.org/10.1111/j.1365-2354.2007.00797.x
30 https://doi.org/10.1177/1758834016644155
31 https://doi.org/10.1200/jco.2004.08.163
32 https://doi.org/10.1200/jco.2007.15.0375
33 https://doi.org/10.1200/jco.2009.23.6406
34 https://doi.org/10.1200/jco.2010.34.4614
35 https://doi.org/10.1200/jco.2012.48.1911
36 https://doi.org/10.1200/jco.2014.57.2347
37 https://doi.org/10.1200/jco.2015.65.4327
38 https://doi.org/10.1248/bpb.b15-00162
39 https://doi.org/10.1248/bpb.b15-00435
40 https://doi.org/10.1371/journal.pone.0171066
41 https://doi.org/10.2478/raon-2013-0086
42 schema:datePublished 2017-12
43 schema:datePublishedReg 2017-12-01
44 schema:description Pemetrexed is a key anticancer agent for treatment of advanced non-small cell lung cancer (NSCLC). Pemetrexed is generally well tolerated, but individual-patient differences exist in severity of adverse events. Our study aimed to characterize the adverse events of pemetrexed that result in discontinuation of chemotherapy and to identify risk factors associated with those adverse events. We retrospectively studied the incidence of adverse events in 257 patients with NSCLC who received pemetrexed (P) with or without bevacizumab (B) and/or carboplatin (C): P, PB, CP, or CPB. Patients whose chemotherapy was discontinued were divided into two groups according to adverse events and disease progression. Grade 2/3 nausea, fatigue with P and PB, and rash with CP and CPB occurred more frequent in the adverse events group than in the disease progression group. Multivariate analysis indicated that grade 2/3 nausea [odds ratio (OR) 9.94; 95% confidence interval (CI) 1.46-67.37; p = 0.01] and fatigue (OR 10.62; CI 1.60-70.20; p = 0.01) with P or PB, and rash (OR 6.12; CI 1.34-27.88; p = 0.01) with CP or CPB, were independent risk factors for discontinuation of chemotherapy. Administration of dexamethasone at doses less than 4 mg after the day of pemetrexed administration was associated with nausea following P or PB (OR 11.08; 95% CI 1.02-119.95; p = 0.04). Grade 2/3 nausea and fatigue with P or PB, and rash with CP or CPB, were associated with discontinuation of chemotherapy.
45 schema:genre research_article
46 schema:inLanguage en
47 schema:isAccessibleForFree false
48 schema:isPartOf N1fda3a45b98148efa1807f4358482496
49 N950bdb1b01e6424cadbd0c8a5b2d3954
50 sg:journal.1094524
51 schema:name Severity and predictive factors of adverse events in pemetrexed-containing chemotherapy for non-small cell lung cancer
52 schema:pagination 195
53 schema:productId N07a868a0e4b345c493daf997eb4379aa
54 N39b4c11abdb2433ab05983bd4560c2d3
55 N3c1164f46ce24a9094fb3db967de834e
56 N6e11d26278274d108a6edd209de917a5
57 Nc9b8eff716ee4a2aa59b542b1241d8f8
58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092595156
59 https://doi.org/10.1007/s12032-017-1053-8
60 schema:sdDatePublished 2019-04-10T16:56
61 schema:sdLicense https://scigraph.springernature.com/explorer/license/
62 schema:sdPublisher N5aee1f3a848f427fbfec6882e674abab
63 schema:url https://link.springer.com/10.1007%2Fs12032-017-1053-8
64 sgo:license sg:explorer/license/
65 sgo:sdDataset articles
66 rdf:type schema:ScholarlyArticle
67 N07a868a0e4b345c493daf997eb4379aa schema:name readcube_id
68 schema:value fea40887dbeb99fea78c82970895b0b0ef40758882bf1bb4e65fb44d0afc4a8c
69 rdf:type schema:PropertyValue
70 N0d03cdc47a1a419da0499b54ad2881de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
71 schema:name Retrospective Studies
72 rdf:type schema:DefinedTerm
73 N13d348274d824300af66bc978eefb86d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Middle Aged
75 rdf:type schema:DefinedTerm
76 N1fda3a45b98148efa1807f4358482496 schema:volumeNumber 34
77 rdf:type schema:PublicationVolume
78 N20abdf57895d4aeaa57ca50349774574 rdf:first sg:person.01114031552.47
79 rdf:rest N4256d1db3c734bbe9c457f9efd3cbb62
80 N303fb4d45b8947ae8656b5929bcf28f1 rdf:first sg:person.016704032752.24
81 rdf:rest rdf:nil
82 N38d1c128e78c442cb87978823b427cb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Male
84 rdf:type schema:DefinedTerm
85 N39b4c11abdb2433ab05983bd4560c2d3 schema:name dimensions_id
86 schema:value pub.1092595156
87 rdf:type schema:PropertyValue
88 N3bfc703b0a7d447cae63ff3e87549892 rdf:first N3d4e2a470e4546c9a878f3d09b9c8a6f
89 rdf:rest N303fb4d45b8947ae8656b5929bcf28f1
90 N3c1164f46ce24a9094fb3db967de834e schema:name pubmed_id
91 schema:value 29124473
92 rdf:type schema:PropertyValue
93 N3d4e2a470e4546c9a878f3d09b9c8a6f schema:affiliation https://www.grid.ac/institutes/grid.416533.6
94 schema:familyName Matsunaga
95 schema:givenName Hisashi
96 rdf:type schema:Person
97 N3e68c45036a7456e928d5eaca4b537ac rdf:first sg:person.01055604713.53
98 rdf:rest N928a1adb0c2d466f9a70f7d24b2af557
99 N4256d1db3c734bbe9c457f9efd3cbb62 rdf:first sg:person.01014670366.36
100 rdf:rest N4e77a7b4e4254dba97cab61ae38ccfe2
101 N4cb6ba5c46424095a04c20a69f8ee2f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Risk Factors
103 rdf:type schema:DefinedTerm
104 N4e77a7b4e4254dba97cab61ae38ccfe2 rdf:first sg:person.01372477264.45
105 rdf:rest Nb189347189ee48df94f761898d6a9a05
106 N51b70b1b5e134934b62852ef6c480464 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Lung Neoplasms
108 rdf:type schema:DefinedTerm
109 N5aee1f3a848f427fbfec6882e674abab schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N5e29e298a4404138b91a1571b8aa0a16 rdf:first sg:person.01307617466.20
112 rdf:rest N3bfc703b0a7d447cae63ff3e87549892
113 N600175f54eeb40408804da710c765f08 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Carcinoma, Non-Small-Cell Lung
115 rdf:type schema:DefinedTerm
116 N6e11d26278274d108a6edd209de917a5 schema:name doi
117 schema:value 10.1007/s12032-017-1053-8
118 rdf:type schema:PropertyValue
119 N7491dac1c2254bbcb7241ad2b89c18c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Female
121 rdf:type schema:DefinedTerm
122 N90690f330828419bb8b71f443338520e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Antineoplastic Combined Chemotherapy Protocols
124 rdf:type schema:DefinedTerm
125 N9096378dd6d7460995607a97b36920af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Fatigue
127 rdf:type schema:DefinedTerm
128 N928a1adb0c2d466f9a70f7d24b2af557 rdf:first sg:person.01352744600.38
129 rdf:rest Nacd42799b9ac433da34ad158621a3399
130 N950bdb1b01e6424cadbd0c8a5b2d3954 schema:issueNumber 12
131 rdf:type schema:PublicationIssue
132 Nacd42799b9ac433da34ad158621a3399 rdf:first sg:person.010703513405.18
133 rdf:rest N5e29e298a4404138b91a1571b8aa0a16
134 Nb189347189ee48df94f761898d6a9a05 rdf:first sg:person.01236516200.77
135 rdf:rest N3e68c45036a7456e928d5eaca4b537ac
136 Nbc40e6a547774419929b7a1d0e682eb3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Pemetrexed
138 rdf:type schema:DefinedTerm
139 Nc9b8eff716ee4a2aa59b542b1241d8f8 schema:name nlm_unique_id
140 schema:value 9435512
141 rdf:type schema:PropertyValue
142 Nc9eb825383e846c4892ad47dd4da1929 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
143 schema:name Nausea
144 rdf:type schema:DefinedTerm
145 Nee876fad41fc4ad5826644f43b5ed165 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
146 schema:name Aged
147 rdf:type schema:DefinedTerm
148 Nf069d7ec36b14e7abb7a35f67fd72258 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Aged, 80 and over
150 rdf:type schema:DefinedTerm
151 Nf6a7814805734dfdb8f7534656979d3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Humans
153 rdf:type schema:DefinedTerm
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 schema:name Medical and Health Sciences
156 rdf:type schema:DefinedTerm
157 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
158 schema:name Oncology and Carcinogenesis
159 rdf:type schema:DefinedTerm
160 sg:journal.1094524 schema:issn 1357-0560
161 1559-131X
162 schema:name Medical Oncology
163 rdf:type schema:Periodical
164 sg:person.01014670366.36 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
165 schema:familyName Sueoka-Aragane
166 schema:givenName Naoko
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01014670366.36
168 rdf:type schema:Person
169 sg:person.01055604713.53 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
170 schema:familyName Komiya
171 schema:givenName Kazutoshi
172 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01055604713.53
173 rdf:type schema:Person
174 sg:person.010703513405.18 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
175 schema:familyName Nakashima
176 schema:givenName Chiho
177 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010703513405.18
178 rdf:type schema:Person
179 sg:person.01114031552.47 schema:affiliation https://www.grid.ac/institutes/grid.416533.6
180 schema:familyName Miyahara
181 schema:givenName Tsuyoshi
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114031552.47
183 rdf:type schema:Person
184 sg:person.01236516200.77 schema:affiliation https://www.grid.ac/institutes/grid.416533.6
185 schema:familyName Ureshino
186 schema:givenName Norio
187 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236516200.77
188 rdf:type schema:Person
189 sg:person.01307617466.20 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
190 schema:familyName Abe
191 schema:givenName Tomonori
192 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307617466.20
193 rdf:type schema:Person
194 sg:person.01352744600.38 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
195 schema:familyName Nakamura
196 schema:givenName Tomomi
197 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01352744600.38
198 rdf:type schema:Person
199 sg:person.01372477264.45 schema:affiliation https://www.grid.ac/institutes/grid.416533.6
200 schema:familyName Iwanaga
201 schema:givenName Kentaro
202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372477264.45
203 rdf:type schema:Person
204 sg:person.016704032752.24 schema:affiliation https://www.grid.ac/institutes/grid.412339.e
205 schema:familyName Kimura
206 schema:givenName Shinya
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016704032752.24
208 rdf:type schema:Person
209 sg:pub.10.1007/s00280-016-3078-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017315212
210 https://doi.org/10.1007/s00280-016-3078-7
211 rdf:type schema:CreativeWork
212 sg:pub.10.1007/s00520-011-1248-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1041097987
213 https://doi.org/10.1007/s00520-011-1248-z
214 rdf:type schema:CreativeWork
215 sg:pub.10.1007/s10147-015-0852-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044954901
216 https://doi.org/10.1007/s10147-015-0852-1
217 rdf:type schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1075203218 schema:CreativeWork
219 https://app.dimensions.ai/details/publication/pub.1083239815 schema:CreativeWork
220 https://doi.org/10.1016/j.critrevonc.2008.01.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036054386
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/s0140-6736(05)67110-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009533002
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/s0140-6736(99)06290-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1046217291
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1016/s1470-2045(12)70063-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012995827
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1056/nejm199107183250305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005599331
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1097/01.jto.0000268672.57002.69 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017316702
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1111/j.1365-2354.2007.00797.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1011948574
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1177/1758834016644155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064077386
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1200/jco.2004.08.163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016594110
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1200/jco.2007.15.0375 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011587624
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1200/jco.2009.23.6406 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044485340
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2010.34.4614 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014939429
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2012.48.1911 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036238424
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1200/jco.2014.57.2347 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007601946
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1200/jco.2015.65.4327 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204500
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1248/bpb.b15-00162 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005897873
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1248/bpb.b15-00435 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014744057
253 rdf:type schema:CreativeWork
254 https://doi.org/10.1371/journal.pone.0171066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083533995
255 rdf:type schema:CreativeWork
256 https://doi.org/10.2478/raon-2013-0086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005021102
257 rdf:type schema:CreativeWork
258 https://www.grid.ac/institutes/grid.412339.e schema:alternateName Saga University
259 schema:name Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan
260 rdf:type schema:Organization
261 https://www.grid.ac/institutes/grid.416533.6 schema:alternateName Saga-Ken Medical Centre Koseikan
262 schema:name Department of Pharmacy, Saga-Ken Medical Centre Koseikan, Saga, Japan
263 Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Faculty of Medicine, Saga University, 849-8501, Saga, Japan
264 Division of Medical Oncology, Saga-Ken Medical Centre Koseikan, Saga, Japan
265 Division of Respiratory Medicine, Saga-Ken Medical Centre Koseikan, Saga, Japan
266 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...